Table 2.
Clinical and urodynamic parameters before and at completion of PTNS treatment.
| Parameters | Pre-treatment | Post-treatment | P-value | |
|---|---|---|---|---|
| Clinical parameters | Micturition Frequency Daily | 15.10 ± 1.61 | 12.00 ± 4.56 | 0.0119 |
| Mean Voiding Volume (mL) | 130.10 ± 53.07 | 157.30 ± 66.95 | 0.0131 | |
| Number of Incontinence Episodes per Day | 3.20 ± 0.80 | 0.47 ± 0.38 | 0.0004 | |
| OABSS | 9.35 ± 1.39 | 5.9 ± 2.36 | <0.0001 | |
| AUA-SI-QOL | 5.70 ± 0.47 | 3.85 ± 1.04 | <0.0001 | |
| PPBC | 5.70 ± 0.47 | 4.35 ± 0.86 | <0.0001 | |
| Parameters | Pre-treatment | During-treatment | P -value | |
| Urodynamic parameters | 1st SBF (mL) | 87.50 (60.00–167.50) | 150.00 (104.00–211.30) | 0.0001 |
| MBC (mL) | 175.00 (120.30–354.00) | 255.00 (151.50–491.50) | 0.0001 | |
| Pdet.Max (cmH2O) | 14.50 (5.00–35.25) | 11.00 (6.00–20.00) | 0.0184 | |
| Mean compliance (mL/cmH2O) | 36.67 (12.44–39.69) | 40.00 (20.00–52.50) | 0.0003 |